Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Borja Gómez-Vila"'
Autor:
Cristina Galache Osuna, Borja Gómez-Vila, Javier Aubán Pariente, Beatriz Vázquez Losada, Celia Gómez de Castro, Sheila Requena López, Álvaro de Dios Velázquez, Laura Palacios García, Lucía Ordoñez Fernández, Santiago Gómez Diez, Francisco Vázquez López, Jorge Santos-Juanes
Publikováno v:
Medicina, Vol 56, Iss 11, p 584 (2020)
Background and objectives: The efficacy and safety of ustekinumab have been proved in clinical trials. In daily clinical practice, knowing the factors that determine survival differences of biological drugs allows psoriasis treatment to be optimized
Externí odkaz:
https://doaj.org/article/03bd0b774a704ee5b7cf1066970f466d
Publikováno v:
Anales de Pediatría.
Autor:
Franciso Vázquez-López, Borja Gómez-Vila, Celia Gómez Castro, Carmén Cadarso-Suárez, Carla Díaz-Louzao, Cristina Galache
The long-term prognosis of patients with chondrodermatitis nodularis (CN) has never been investigated. We developed the empirical hypothesis that the survival of these patients could present differences with controls, based in our own previous experi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de5fc391dba69e4c14466d783191cbd2
https://doi.org/10.21203/rs.3.rs-1496471/v1
https://doi.org/10.21203/rs.3.rs-1496471/v1
Autor:
Borja Gómez Vila, Luis Requena, Paola Lara-Valencia, Karolien Van Den Bossche, Eva Sánchez-Martínez, Pedro Zaballos, Juncal Roca-Ginés
Publikováno v:
AMERICAN JOURNAL OF DERMATOPATHOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cutaneous clear cell proliferations encompass a heterogenous group of several primary cutaneous neoplasms and metastatic tumors with different histogenesis. Many of these clear cell proliferations may seem strikingly similar under the microscope resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2329a258d6823a1f861c4800a2f76f4d
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14851
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14851
Autor:
Borja Gómez-Vila, Laura Palacios García, Celia Gómez de Castro, Francisco Vázquez López, Jorge Santos-Juanes, Cristina Galache Osuna, Lucía Fernández, Sheila Requena López, Javier Aubán Pariente, Beatriz Vázquez Losada, Santiago Gómez Díez, Álvaro de Dios Velázquez
Publikováno v:
Medicina
Volume 56
Issue 11
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Medicina, Vol 56, Iss 584, p 584 (2020)
Medicina; Volume 56; Issue 11; Pages: 584
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Volume 56
Issue 11
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Medicina, Vol 56, Iss 584, p 584 (2020)
Medicina; Volume 56; Issue 11; Pages: 584
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Background and objectives: The efficacy and safety of ustekinumab have been proved in clinical trials. In daily clinical practice, knowing the factors that determine survival differences of biological drugs allows psoriasis treatment to be optimized
Publikováno v:
Medicina Clínica. 157:98